Osteoarthritis Market Set to Reach $10.64 Billion by 2029 with 9% Yearly Growth

What market dynamics are playing a key role in accelerating the growth of the osteoarthritis market?
The growth of the osteoarthritis market is anticipated to be fueled by an increasing prevalence of obesity-related health disorders. These health concerns stem from excessive body fat, which can be the result of high-calorie consumption, poor diet choices like fast food, and alcohol over-consumption. Obesity can lead to osteoarthritis by placing high pressure on the joints, causing inflammation and hormone disruption, which places additional load on the joints. For example, The World Obesity Atlas 2022, published by the World Obesity Federation, a non-profit organization from the UK, projects that by 2030, 1 billion global citizens including 1 in 7 men and 1 in 5 women will have obesity. By 2035, it expects 4 billion or 51% of the world's population to be either overweight or obese. Consequently, the rise of obesity-related health problems is powering the expansion of the osteoarthritis market. A prevalent usage of painkillers is also expected to stimulate the osteoarthritis market's growth. Painkillers, medications designed to mitigate pain, function by lessening pain perception and are often deployed to ease discomfort stemming from several conditions or injuries. The common usage of painkillers in managing osteoarthritis, especially when it comes to providing effective pain relief, can significantly influence the osteoarthritis market. This can lead to higher product demand, shape treatment protocols, boost research and development initiatives, and also increase awareness about osteoarthritis. For example, a study by the US-based Consumer Healthcare Products Association in June 2022 revealed that around 80% of participants reported their use of over-the-counter pain relievers has either stayed the same (49%) or escalated (30%) over the past two years. Hence, the common usage of painkillers is propelling the osteoarthritis market growth.

Get Your Osteoarthritis Market Report Here:
https://www.thebusinessresearchcompany.com/report/osteoarthritis-global-market-report

How will the growth rate of the osteoarthritis market shape industry trends by 2034?
The market size of osteoarthritis has witnessed robust growth in the past years. It is expected to surge from $6.87 billion in 2024 to approximately $7.53 billion in 2025 with an impressive compound annual growth rate (CAGR) of 9.6%. Factors such as an aging population, obesity crisis, advancements in imaging techniques, and the evolution of pain management strategies have contributed to the growth in the past period.

The market size of osteoarthritis is projected to witness substantial growth in the ensuing years, expected to rise to $10.64 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The upsurge within the forecast period is largely due to non-pharmacological techniques, disease-altering osteoarthritis medication (dmoads), customized treatments, telehealth, and remote monitoring systems. Key trends during the forecast period will be regenerative treatments, wearable technology, use of artificial intelligence in diagnostics, and digital health tools.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13022&type=smp

What trends are poised to drive the future success of the osteoarthritis market?
To enhance technology integration and broaden their market presence, key players in the osteoarthritis market are employing a strategic partnership approach. A strategic partnership generally refers to a cooperative agreement between two or more organizations where they pool their resources, skills, and efforts to accomplish shared goals or objectives. For example, LG Chem, a pharmaceutical company based in South Korea, penetrated the Chinese market in July 2024 through collaboration with Yifan Pharmaceutical Co., Ltd., a China-based firm focused on pharmaceutical research and manufacture. This collaboration aimed to introduce Synovian injection, an osteoarthritis treatment. Synovian provides comparable therapeutic benefits to traditional multi-injection treatments but requires only a single administration. Synovian's unique attributes consist of its high molecular weight (10 million Dalton) hyaluronic acid, which boosts viscoelasticity and joint function, and its proven capacity to significantly alleviate knee pain, as shown in clinical Phase 3 trial results. Consequently, Synovian has emerged as an efficient solution for patients seeking convenient alleviation of osteoarthritis symptoms.

Which primary segments of the osteoarthritis market are driving growth and industry transformations?
The osteoarthritis market covered in this report is segmented -

1) By Treatment: Medication, Surgery, Therapy
2) By Diagnosis: Imaging, Joint Fluid Analysis
3) By Route Of Administration: Parenteral Route, Topical Route, Oral Route
4) By Disease Type: Knee Osteoarthritis, Spine Osteoarthritis, Foot And Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis
5) By End-User: Hospitals, Medical Institutes

Subsegments:
1) By Medication: Pain Relievers, Corticosteroids, Hyaluronic Acid Injections, Disease-Modifying Osteoarthritis Drugs (DMOADs)
2) By Surgery: Joint Replacement Surgery, Arthroscopy, Osteotomy, Joint Fusion
3) By Therapy: Physical Therapy, Occupational Therapy, Weight Management Programs, Assistive Devices

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13022

Which geographical regions are pioneering growth in the osteoarthritis market?
North America was the largest region in the osteoarthritis market in 2024. The regions covered in osteoarthritis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Who are the influential players reshaping the osteoarthritis market landscape?
Major companies operating in the osteoarthritis market are Pfizer Inc., Johnson & Johnson, Merck Sharp & Dohme Corp., Abbvie Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca PLC, Abbott Laboratories Incorporation, Eli Lilly and Company, Boehringer Ingelheim, Novo Nordisk A/S, Reckitt Benckiser Group PLC, Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Astellas Pharma Inc., Zimmer Biomet Holdings Inc., Eisai Co. Ltd., Horizon Therapeutics PLC, Apotex Inc., Mallinckrodt Pharmaceuticals, Pacira BioSciences Inc., Bioventus Inc., Endo Pharmaceuticals Inc., Assertio Therapeutics Inc., Anika Therapeutics Inc., Abiogen Pharma Spa, Kolon TissueGene Inc., Ampio Pharmaceuticals Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=13022&type=smp

What Is Covered In The Osteoarthritis Global Market Report?

•Market Size Forecast: Examine the osteoarthritis market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the osteoarthritis market for a structured understanding.
•Key Players Overview: Analyze major players in the osteoarthritis market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the osteoarthritis market.
•Segment Contributions: Evaluate how different segments drive overall growth in the osteoarthritis market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the osteoarthritis market.
•Industry Challenges: Identify potential risks and obstacles affecting the osteoarthritis market.
•Competitive Landscape: Review strategic developments in the osteoarthritis market, including expansions, agreements, and new product launches.

Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.